Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Status:
SUSPENDED
Trial end date:
2028-06-30
Target enrollment:
Participant gender:
Summary
The goal of this open-label, randomized trial is to assess the efficacy of doxycycline prophylaxis in reducing incidences of bacterial sexually transmitted infections (STIs) among adolescent and young adult females while also evaluating acceptability and antimicrobial resistance in order to inform public health policy.
Phase:
PHASE4
Details
Lead Sponsor:
Westat
Collaborators:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Florida State University National Institute of Allergy and Infectious Diseases (NIAID)/Division of AIDS (DAIDS) National Institute of Mental Health (NIMH) National Institute on Drug Abuse (NIDA) National Institutes of Health (NIH)